|
|
 |
|
Viewing report
|
|
|
|
Partnering in the Global Generics Industry 2008: A Guide to Companies
Espicom Business Intelligence Ltd, July 2008, Pages: 406
Identify merger, acquisition and partner candidates in the rapidly changing global generics market. Consolidation runs throughout the generic industry. Here’s just a taste of the acquisitions and controlling investments in 2007/08:
- Target
- Strides
- TAD
- AxiCorp GmbH
- Medicamenta
- Kyowa Pharmaceutical
- Alkan Pharma
- Hisyn Pharmaceutical
- Buyer
- Genepharm
- Aurobindo
- Biocon
- Glenmark
- Lupin Laboratories
- Hikma
- Hovione
Teva and Sandoz may be fighting it out for the top spot but the medium-sized corporate landscape is changing just as vigorously.
Strategic partnering:
In addition to outright purchase, strategic partnering or the acquisition of specific drug assets is on the rise as companies seek to bring lower costs and focus to their portfolios. With business cycles growing shorter and shorter, market entry is quicker and more reliable through acquisition and partnering.
Drivers for change:
In addition to ongoing expansion, there are other drivers which are causing the generic companies to consider the future:
- The number of new generic drug opportunities is reducing in line with the decline in NDAs over recent years. Furthermore, the branded industry is far more aware of the potential to protect revenues by issuing early branded generics, new formulations or combination products.
- The increasing introduction of biotech based products will present regulatory and production hurdles to generic manufacturers in the future.
Identify new business opportunities and assess risk:
For everyone needing to evaluate the generic industry’s competitive landscape, this new, thoroughly researched 406-page report Partnering in the Global Generics Industry 2008:
- A guide to companies (published July 2008) is an essential business reference.
- Unbeatable coverage
- For each company where available or appropriate
- Background
A Summary of the Company’s Foundation and Main Business Interests
- Product Range
Details of Andas Approved or Products Represented
- Financial
Financial Performance or Funding Data
- Strategic Alliances
Details of Significant Marketing and Supply Agreements
- Contact Information
Use this report to:
- Identify commercial partners
- Understand the developing generic industry in key markets worldwide
- Profile the competitive environment in the increasingly important medium-sized company sector
- Seek out companies manufacturing/marketing similar product lines
- Assess the investment potential of these developing companies
- 163 companies from 40 countries evaluated
Customers who bought this item also bought
Partnering in the Global Generics Industry 2009: A Guide to Companies
Pharmaceuticals - Global Outlook
Emerging Generic Drug Companies Worldwide 2007
RFID for Healthcare and Pharmaceuticals 2009-2019
RFID for Healthcare and Pharmaceuticals 2008-2018
M356 ANDA Review Call - Momenta Pharmaceuticals, Inc., - Earnings Transcript
Dairy Products - Global Outlook
Contact Lenses and Solutions - Global Strategic Business Report
Watson Pharmaceuticals Generics Company Intelligence Report
Pharmaceuticals - Global Outlook 2006
Pharmaceuticals: Global Industry Guide
Contact Lenses and Solutions - A Global Market Review
|
|
|
|
